← Back to headlines
Regenxbio Shares Climb Following Positive Duchenne Trial Results
Regenxbio's shares have increased after the company announced positive results from its Duchenne trial.
14 May, 14:09 — 14 May, 14:09
Sources
Showing 1 of 1 sources
Regenxbio's shares have increased after the company announced positive results from its Duchenne trial.